Thar Pharmaceuticals acquired by German company

Pittsburgh-based Thar Pharmaceuticals has been acquired by Gr ünenthal, a German-based pharmaceutical company. A purchase price wasn't disclosed. Grünenthal said in a statement Wednesday announcing the purchase that Thar's compound, T121, would be used to help expand its own treatment of Complex Regional Pain Syndrome, which is marked by severe and persiste nt pain. The deal includes the worldwide development and commercialization rights for T121. Thar Pharmaceuticals worked to make IV-only drugs…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news